Low LDL causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 26: | Line 26: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Dyskeratosis congenita]], [[Lipoma|lipomatosis of Madelung]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[Clofibrate]], [[colesevelam hydrochlorie]], [[colestyramine]], [[doxazosin | |bgcolor="Beige"| [[Clofibrate]], [[Colesevelam (patient information)|colesevelam hydrochlorie]], [[colestyramine]], [[doxazosin]], [[nicotinic acid]], [[NSAID]], [[prazosin]], [[probucol]], [[statins]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 46: | Line 46: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| [[Celiac disease]], [[chronic liver disease]], [[chronic pancreatitis]], [[cirrhosis]], [[Crohn's disease]], [[exocrine pancreatic insufficiency]], [[intestinal lymphangiectasia]], [[liver failure]], [[portosystemic shunts]], [[protein losing | |bgcolor="Beige"| [[Celiac disease]], [[chronic liver disease]], [[chronic pancreatitis]], [[cirrhosis]], [[Crohn's disease]], [[exocrine pancreatic insufficiency]], [[Lymphangiectasia|intestinal lymphangiectasia]], [[liver failure]], [[Transjugular intrahepatic portosystemic shunt|portosystemic shunts]], [[protein losing enteropathy]], [[short bowel syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[ | |bgcolor="Beige"| [[Abetalipoproteinemia]], [[apolipoprotein B deficiency]], [[Abetalipoproteinemia|Bassen-Kornzweig disease]], [[cystic fibrosis]], [[PCSK9#PCSK9 Deficiency|deficiency of proprotein convertase subtilisin-like/kexin type 9]], [[dyskeratosis congenita]], [[familial alphalipoprotein deficiency]], [[familial hypobetalipoproteinemia]], [[Hyperlipoproteinemia|hyperlipoproteinemia, familial type 5]], [[hypobetalipoproteinemia]], [[lipoprotein lipase deficiency]], [[Abetalipoproteinemia|mutations of the MTTP gene]], [[Shwachman-Diamond syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| Line 134: | Line 134: | ||
*[[Amyloidosis]] | *[[Amyloidosis]] | ||
*[[Apolipoprotein B deficiency]] | *[[Apolipoprotein B deficiency]] | ||
*[[Autoimmune diseases]] | *[[Autoimmune diseases]] | ||
*[[Bassen-Kornzweig disease | *[[Abetalipoproteinemia|Bassen-Kornzweig disease]] | ||
*[[Celiac disease]] | *[[Celiac disease]] | ||
*[[Chronic liver disease]] | *[[Chronic liver disease]] | ||
| Line 143: | Line 141: | ||
*[[Cirrhosis]] | *[[Cirrhosis]] | ||
*[[Clofibrate]] | *[[Clofibrate]] | ||
*[[Colesevelam hydrochlorie]] | *[[Colesevelam (patient information)|Colesevelam hydrochlorie]] | ||
*[[Colestyramine]] | *[[Colestyramine]] | ||
*[[Crohn's disease]] | *[[Crohn's disease]] | ||
*[[Cystic fibrosis]] | *[[Cystic fibrosis]] | ||
*[[Deficiency of proprotein convertase subtilisin-like/kexin type 9 | {{col-break|width=33%}} | ||
*[[PCSK9#PCSK9 Deficiency|Deficiency of proprotein convertase subtilisin-like/kexin type 9]] | |||
*[[Doxazosin]] | *[[Doxazosin]] | ||
*[[Dyskeratosis congenita]] | *[[Dyskeratosis congenita]] | ||
| Line 155: | Line 153: | ||
*[[Familial hypobetalipoproteinemia]] | *[[Familial hypobetalipoproteinemia]] | ||
*[[Giardiasis]] | *[[Giardiasis]] | ||
*[[Hyperlipoproteinemia, familial type 5]] | *[[Hyperlipoproteinemia|Hyperlipoproteinemia, familial type 5]] | ||
*[[Hypobetalipoproteinemia]] | *[[Hypobetalipoproteinemia]] | ||
*[[Inflammatory cytokines]] | *[[Inflammatory cytokines]] | ||
*[[Intestinal lymphangiectasia]] | *[[Lymphangiectasia|Intestinal lymphangiectasia]] | ||
*[[Ketogenic diet]] | *[[Ketogenic diet]] | ||
*[[ | *[[Lipoma|Lipomatosis of Madelung]] | ||
*[[Lipoprotein lipase deficiency]] | *[[Lipoprotein lipase deficiency]] | ||
*[[Liver failure]] | |||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Malignancy]] | *[[Malignancy]] | ||
*[[Malnutrition]] | *[[Malnutrition]] | ||
*[[Ménétrier's disease]] | *[[Ménétrier's disease]] | ||
*[[Mutations of the MTTP gene]] | *[[Abetalipoproteinemia|Mutations of the MTTP gene]] | ||
*[[Nicotinic acid]] | *[[Nicotinic acid]] | ||
*[[NSAID | *[[NSAID]] | ||
*[[Portosystemic shunts]] | *[[Transjugular intrahepatic portosystemic shunt|Portosystemic shunts]] | ||
*[[Prazosin]] | *[[Prazosin]] | ||
*[[Probucol]] | *[[Probucol]] | ||
*[[Protein losing | *[[Protein losing enteropathy]] | ||
*[[Serum amyloid A]] | *[[Serum amyloid A]] | ||
*[[Short bowel syndrome]] | *[[Short bowel syndrome]] | ||
Revision as of 20:31, 6 November 2013
|
Low Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Low LDL causes On the Web |
|
American Roentgen Ray Society Images of Low LDL causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Rim Halaby, M.D. [3]; Vendhan Ramanujam M.B.B.S [4]
Overview
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.